## **Core Concept**
Latanoprost is a prostaglandin F2α analogue used in the treatment of glaucoma. It primarily works by increasing the outflow of aqueous humor from the eye, thereby reducing intraocular pressure (IOP). This mechanism is crucial in managing glaucoma, a condition characterized by elevated IOP that can lead to optic nerve damage.

## **Why the Correct Answer is Right**
The correct answer, , indicates that latanoprost acts by increasing uveoscleral outflow. Latanoprost, like other prostaglandin analogues, exerts its effect by binding to prostaglandin F receptors in the eye. This binding leads to an increase in the uveoscleral outflow of aqueous humor, which is an alternative pathway for aqueous humor drainage. This mechanism results in a decrease in intraocular pressure, providing therapeutic benefit in glaucoma patients.

## **Why Each Wrong Option is Incorrect**
- **Option A:** . This option suggests decreasing aqueous humor production, which is not the primary mechanism of action for latanoprost. While some glaucoma medications do work by reducing aqueous humor production, this is not how latanoprost functions.
- **Option B:** . This option implies a non-specific effect or a mechanism not directly related to the known action of latanoprost. Latanoprost's effect is well-defined and specific to increasing uveoscleral outflow.
- **Option C:** . This option might refer to trabecular meshwork outflow, which is the conventional outflow pathway but not the primary one affected by latanoprost.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that prostaglandin analogues like latanoprost can cause changes in iris pigmentation and eyelash growth with long-term use. Clinicians should inform patients about these potential side effects when initiating therapy.

## **Correct Answer:** . increasing uveoscleral outflow.